- $5.16m
- $2.90m
- $2.44m
Annual income statement for Taoweave, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.74 | 5.48 | 3.81 | 2.38 | 2.44 |
| Cost of Revenue | |||||
| Gross Profit | 2.72 | 1.55 | 0.911 | 0.331 | 1.01 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 17.1 | 27.5 | 8.3 | 6.58 | 5.4 |
| Operating Profit | -9.35 | -22 | -4.5 | -4.2 | -2.96 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -9.14 | -21.9 | -4.36 | -4.03 | -6.35 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.05 | -21.9 | -4.38 | -4.04 | -6.36 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.05 | -21.9 | -4.38 | -4.04 | -6.36 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.76 | -21.9 | -5.5 | -13.1 | -6.39 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -6.26 | -6.44 | -1 | -15.7 | -2.76 |